Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. - Wikidata - awgldk - TriplyDB

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

http://www.wikidata.org/entity/Q35092898

about

Lupus pathobiology based on genomics.Mechanisms of Autoantibody-Induced Pathology.Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Fatal cardiac involvement complicating antisynthetase syndrome.The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis.Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.Pure White Cell Aplasia and Necrotizing Myositis The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.Latest advances in connective tissue disorders.Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders.T cells in myositis.Autoantibodies in polymyositis and dermatomyositis.Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases.[New aspects on the pathogenesis of myositis].A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease.Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China

P2860

Q33364409-1369D3CF-DD1C-46CE-89FC-4F915E69F9BD Q33740580-09920969-7D33-4833-8E85-6BDD975E83DD Q33814323-95F7634E-6DBC-47DA-94AF-93075AEF28FD Q34130694-577A4FE1-14D4-4F34-8113-63970D6AAAC0 Q34560305-39414432-6196-4D9A-A459-2E2DEED34FD3 Q35095086-9FBA0331-D137-4C77-851A-E9157941F989 Q35153899-2AC3BD41-3EC5-4776-AC5A-23D53603B490 Q36086954-C61E228F-72C2-484E-AFA4-069E2213FE5F Q36245820-3D77DBC1-4A33-46B2-999C-B3123A7F4B77 Q36335887-E7C3D044-6AD5-45C0-A6C7-DC7EEB3CCFC7 Q36747683-ED5D2E06-D8B8-4107-B604-BFB583F5AF22 Q37040711-FEAF0EA2-6766-475E-B06D-3413716A823C Q37058776-FB14B026-5FA4-4FC9-AE44-4BA6C3215CAA Q37073571-7E040F31-5662-42D9-9222-CA4EBDCC0725 Q37368405-29318B5C-56B3-442C-AF28-F2849E07F22C Q37674765-A6356F80-185D-460C-AA43-80F0163E09D3 Q37956169-F14E4C8F-78AA-4349-A645-0AFC656CEC55 Q38070033-4EFC0C2C-DD3A-4E19-865C-3A579215DC8F Q38099556-1082B811-25BE-4FEC-8807-DF1D90BFD19D Q38124282-52FECE6D-1245-49A9-B719-F657E45CF781 Q38130904-2AD7F814-81C0-44FD-BF07-D022DA77E569 Q38221095-FA8EC31C-2D41-4B54-9005-E5C013141CA3 Q38554195-B1CE9590-716B-4D14-885E-7A14F7F9E7A4 Q38589301-773C05E9-E2FC-46F5-AD12-E142A18F01B3 Q38646384-1AE95329-90D8-449B-83D0-CB16549F8B73 Q38664251-7957091A-F8AB-4A9E-B5DC-5118E63C4159 Q39198820-038D4A1B-CE62-48A3-91FF-F20BB28F6B9F Q43978656-DF8F1A6C-A5E1-476D-ACC8-18E817273048 Q53790402-C4CBFE3C-9432-4085-A8E4-6BAB7A92E216 Q54351638-7221CAC5-C119-41D7-A386-08D6C701FF0E Q57788718-C57AE417-B584-4EF7-B729-F4FF570DAC42

P2860

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

http://www.wikidata.org/entity/Q35092898

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

@ast

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

@en

type

label

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

@ast

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

@en

prefLabel

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

@ast

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

@en

P1433

Q35092898-A179412E-C41A-46F2-A416-2E1C9A8E31E9

P1476

Q35092898-50A1B545-5B4B-42A1-8AA5-9C602EE72663

P2093

Q35092898-47871E2E-A4AD-476F-9394-5F2CE1D054EE

Q35092898-8A998B52-D5E8-492D-8036-64566881A52C

Q35092898-A50C6307-0BA6-4E13-8D12-26AB8E67C8DA

P2860

Q35092898-0AB61BBA-B46F-4AEC-A3DA-860E9D9309AC

Q35092898-0DDF1F3A-E280-43AF-A87F-7C67F86A7D1D

Q35092898-1A55E9FF-7764-4D8F-B45A-6E4C39830CDA

Q35092898-1DFDA50D-5D47-4C5A-97E8-117F8E4923C3

Q35092898-226A95EE-9256-4424-B9C1-860DD9C6F504

Q35092898-25AD1FC2-5E8C-410E-A9E8-A3CE1E97AA4C

Q35092898-2CB4EC92-2FED-4F27-ABCD-FC9D26459C4A

Q35092898-2E4DDF47-0F86-4125-A976-F192C1156186

Q35092898-34AA58B6-B10B-4FED-A740-AAF8746413B6

Q35092898-36523664-7D87-48CB-931A-C7D9148ABE43

P2888

Q35092898-C9EE8AE6-5BCA-4FF8-ACEB-31D39D96EFA9

P304

Q35092898-C05C3D74-B067-4C19-911E-085BD08BA333

P31

Q35092898-A8E7029E-4B0A-411C-9D52-38E82084CC80

Q35092898-F5E7038D-23D2-4392-913A-7C3C2FF26267

P356

Q35092898-DE31C83D-B085-4D91-9A4F-F391B886AA29

P433

Q35092898-9982DC08-C4E8-49D1-83D1-20A383AD03F1

P478

Q35092898-8CEB88E7-E8A7-4EC0-914A-F5C4876BD6B0

P577

Q35092898-C6E06A5D-901E-4617-9021-35D292DF77B9

P5875

Q35092898-C5B3B725-0CCB-415E-81C7-8810C2C6801B

P6179

Q35092898-6F5912AD-24E3-4062-868F-5C39870D87B8

P698

Q35092898-7A78D2F6-E68F-47CD-8E27-195677581EF4

P921

Q35092898-49CEBA62-8BC4-440B-8E14-20E59D6C0849

Q35092898-6A25F3B9-FC22-4E6B-AAB2-BBEEF81DA912

Q35092898-86DC908D-4D92-402D-A3D4-0667D221915D

Q35092898-A778C3F9-1824-489D-9A79-845C6AC0FE36

P932

Q35092898-E1B20AA6-047B-4783-A6AE-12634B6246A1

P356

P1433

Arthritis Research and Therapy

P1476

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.

@en

P2093

Harsha Gunawardena

http://www.w3.org/2001/XMLSchema#string

Neil J McHugh

http://www.w3.org/2001/XMLSchema#string

Zoe E Betteridge

http://www.w3.org/2001/XMLSchema#string

P2860

FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination

The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains

Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis

Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis.

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.

Polymyositis and dermatomyositis (second of two parts).

Polymyositis and dermatomyositis (first of two parts).

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations.

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

P2888

P304

209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3275

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50986554

http://www.w3.org/2001/XMLSchema#string

P6179

1000461478

http://www.w3.org/2001/XMLSchema#string

P698

21457520

http://www.w3.org/2001/XMLSchema#string

P921

P932

3132021

http://www.w3.org/2001/XMLSchema#string